Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Willand

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
ACS Infectious Diseases|February 4, 2020
Fragment-Based Optimized EthR Inhibitors with <i>in Vivo</i> Ethionamide Boosting ActivityBaptiste Villemagne, Arnaud Machelart, Ngoc Chau Tran, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial AcidificationLéo Faïon, Kamel Djaout, Catalin Pintiala, et al.
Nature Medicine|May 5, 2009
Synthetic EthR inhibitors boost antituberculous activity of ethionamideNicolas Willand, Bertrand Dirié, Xavier Carette, et al.
Journal of Medicinal Chemistry|December 6, 2022
Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH DehydrogenasesSushovan Dam, Salia Tangara, Claire Hamela, et al.
Journal of Medicinal Chemistry|June 29, 2012
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesisMarion Flipo, Nicolas Willand, Nathalie Lecat-Guillet, et al.
Journal of Medicinal Chemistry|May 14, 2014
Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approachesBaptiste Villemagne, Marion Flipo, Nicolas Blondiaux, et al.
Journal of Medicinal Chemistry|March 23, 2011
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitorsMarion Flipo, Matthieu Desroses, Nathalie Lecat-Guillet, et al.
Nucleic Acids Research|December 14, 2011
Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligandsXavier Carette, Nicolas Blondiaux, Eve Willery, et al.
Iscience|October 21, 2024
Molecular mechanism of a triazole-containing inhibitor of <i>Mycobacterium tuberculosis</i> DNA gyraseAntoine Gedeon, Emilie Yab, Aurelia Dinut, et al.
Scientific Reports|May 12, 2018
Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticlesJoana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
ACS Infectious Diseases|February 4, 2020
Fragment-Based Optimized EthR Inhibitors with <i>in Vivo</i> Ethionamide Boosting ActivityBaptiste Villemagne, Arnaud Machelart, Ngoc Chau Tran, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial AcidificationLéo Faïon, Kamel Djaout, Catalin Pintiala, et al.
Nature Medicine|May 5, 2009
Synthetic EthR inhibitors boost antituberculous activity of ethionamideNicolas Willand, Bertrand Dirié, Xavier Carette, et al.
Journal of Medicinal Chemistry|December 6, 2022
Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH DehydrogenasesSushovan Dam, Salia Tangara, Claire Hamela, et al.
Journal of Medicinal Chemistry|June 29, 2012
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesisMarion Flipo, Nicolas Willand, Nathalie Lecat-Guillet, et al.
Journal of Medicinal Chemistry|May 14, 2014
Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approachesBaptiste Villemagne, Marion Flipo, Nicolas Blondiaux, et al.
Journal of Medicinal Chemistry|March 23, 2011
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitorsMarion Flipo, Matthieu Desroses, Nathalie Lecat-Guillet, et al.
Nucleic Acids Research|December 14, 2011
Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligandsXavier Carette, Nicolas Blondiaux, Eve Willery, et al.
Iscience|October 21, 2024
Molecular mechanism of a triazole-containing inhibitor of <i>Mycobacterium tuberculosis</i> DNA gyraseAntoine Gedeon, Emilie Yab, Aurelia Dinut, et al.
Scientific Reports|May 12, 2018
Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticlesJoana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
Pageof 5